Erschienen in:
01.01.2013 | Short Communication
Cross-reactivities of 41 new amphetamine designer drugs to EMIT® immunoassays
verfasst von:
Maria Nieddu, Claudia Trignano, Lucia Burrai, Maria Antonietta Pirisi, Gianpiero Boatto
Erschienen in:
Forensic Toxicology
|
Ausgabe 1/2013
Einloggen, um Zugang zu erhalten
Abstract
Amphetamine designer drugs are central nervous system stimulants, and are widely diffused in illegal markets. Monitoring of drugs of abuse in biological fluids is successfully used for clinical and forensic applications. In particular, the urine matrix allows the verification of drug intake in the short and medium term. In a forensic toxicology laboratory, typical analysis for these drugs involves an immunoassay screening method. Here we describe the cross-reactivity profiles of 41 new amphetamine designer drugs to the urine drug tests EMIT® II Plus (Amphetamines assay and Ecstasy assay).